glp-1 receptor agonists in idiopathic intracranial hypertension Use of glucagon-like peptide-1 : a systematic review | The Journal of Headache and Pain A glucagon-like peptide-1 receptor agonist
Description
Bisaga, A., Danysz, W
CAPS Task Force recommendations (2020) and real-world experience support this stepwise approach
Sun B, Willard FS, Feng D, Alsina-Fernandez J, Chen Q, Vieth M, Ho JD, Showalter AD, Stutsman C, Ding L, et al
Retatrutide achieved a decrease in mean body weight at all dose levels except at the dose of 0.1 mg
